AND T
AND T
复制标题
DOI：
--
复制
发表时间：
--
期刊：
影响因子：
--
通讯作者：
MD YOSHIO KINAMI;I. Miyazaki;Mdi
中科院分区：
文献类型：
--
作者：
MD YOSHIO KINAMI;I. Miyazaki;Mdi
对45例不能手术的肝癌患者，采用超选择性或选择性肝动脉一次性注射丝裂霉素C（MMC）15-40 mg。其中14名患者患有原发性肝癌，31名患者患有原发性胃癌或结直肠癌或其他器官的肝转移。7370例患者主观症状改善，60%的患者客观体征改善。19例接受两次以上治疗的患者平均生存时间为10个月，50%生存时间为7.8个月。选择性一次注射法的治疗效果大多在血管丰富的肿瘤患者中得到认可。然而，使用超选择性一次注射方法获得了相当好的结果，即使在肿瘤血管相对较少的患者中也是如此。癌症41：1720-1727，1978。
Forty-five patients with inoperable cancer of the liver were treated by the one shot administration of 15-40 mg of Mitomycin C into the hepatic artery, either by the superselective or by the selective ofie shot method. Fourteen of the patients had primary cancers of the liver, and 31 had metastases to the liver from primary cancers of the stomach, or from the colorectal or other organs. Subjective symptoms improved in 7370, and objective signs improved in 60%. Nineteen patients who received this treatment more than twice showed a mean survival time of 10 months and a 50% survival time of 7.8 months. Therapeutic effects of the selective one shot method were recognized mostly in patients with tumors which were rich in vessels. However, a fairly good result was obtained using the superselective one shot method, even in patients with tumors having relatively few vessels. Cancer 41:1720-1727, 1978.